Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
02/2003
02/26/2003EP1042297B1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
02/26/2003EP0969827B1 Mixture of primary fatty acids obtained from sugar cane wax
02/26/2003EP0850059B1 Pharmaceutical formulations containing darifenacin
02/26/2003CN1399678A Human Enzymes of metalloprotease family
02/26/2003CN1399644A Novel human G-Protein coupled receptor
02/26/2003CN1399638A Indoloazepines as vasopressin receptor antagonists
02/26/2003CN1399636A Adenosine receptor antagonists and methods of making and using the same
02/26/2003CN1399633A 嘧啶衍生物 Pyrimidine derivatives
02/26/2003CN1399632A Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as active ingredient
02/26/2003CN1399631A Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
02/26/2003CN1399573A Use of phthalazine derivatives
02/26/2003CN1399572A Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
02/26/2003CN1399548A Composition for treatment of external secretion disorders
02/26/2003CN1399545A Treatment of certain cancers associated with weight gain
02/26/2003CN1398896A Hybrid peptide with vascularization inhibiting activity
02/26/2003CN1398637A Thymosin alpha-1 microball prepn and its prepn process
02/26/2003CN1398631A Medicine composition with immunoregulating and digestion-promoting functions
02/26/2003CN1398629A Changshuning capsule and its prepn
02/26/2003CN1398622A Medicine for treating digestive tract disease and its prepn
02/26/2003CN1398615A Chinese medicine prepn for treating fatty liver and obesity
02/26/2003CN1398611A Chinese herbal medicine composition for treating caries pain and its prepn
02/26/2003CN1398609A Medicine for eliminating hepatitis virus
02/26/2003CN1398607A Medicine for delaying senility and its prepn
02/26/2003CN1398606A Medicine for treating gastroenteritic diseases
02/26/2003CN1398602A Medicated tea
02/26/2003CN1398594A Application of sodium bicarbonate in preparing medicine for hepatitis
02/26/2003CN1102144C Noval pyrimidine derivatives and prepn. processes thereof
02/26/2003CN1102058C Oral ginger juice liquid
02/26/2003CN1102053C Medical capsule for curing stomach-ache and its production method
02/26/2003CN1102049C Tonic compound deer fetus ointment and its preparation method
02/26/2003CN1102044C Dragon's blood micro sponge agent and its preparing technology
02/26/2003CA2419744A1 A novel crystal of n-hydroxy-2(s)-methyl-5-ethoxymethoxy-4(s)-¬n-(4-phenoxyphenylcarbonyl)amino|pentanamide and a method for the preparation thereof and a pharmaceutical agent comprising the same as active ingredient
02/25/2003US6525242 Preparation of non-human animals having chimeric livers for use of animal models for human liver toxins; immunocompetent animals are rendered tolerant to human hepatocytes by cell or lysate administration during embryonic or neonate stage
02/25/2003US6525241 Expression methods
02/25/2003US6525202 Cyclic amine phenyl beta-3 adrenergic receptor agonists
02/25/2003US6525184 Self-regulated apoptosis of inflammatory cells
02/25/2003US6525178 PGC-1, a novel brown fat PPARgamma coactivator
02/25/2003US6525083 Antidiabetic agents, antilipemic agents, anticholesterol agents
02/25/2003US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists
02/25/2003US6525067 Substituted heterocyclic derivatives
02/25/2003US6525059 Substituted pyrazoles as p38 kinase inhibitors
02/25/2003US6525052 Compounds useful as reversible inhibitors of cysteine proteases
02/25/2003US6525051 For treating cytokine-induced hypotension, inflammatory bowel disease, cerebral ischemia, arthritis, adult respiratory distress syndrome, asthma
02/25/2003US6525048 Aminomethylphenoxymethyl/benzisoxazole substituted azabicyclic compounds; depression, generalized anxiety disorder, obesity, migraine; 2-(5-Fluoro-benzo(d)isoxazol-3-y)-7-(3-morpholin-4-ylmethylphenoxymethyl) -octahydro-pyrido(1,2-a)pyrazine;
02/25/2003US6525040 4,4-dimethyl-thieno-(3,2-e)-isoselenazine; antioxidants and cytoprotecting
02/25/2003US6525036 Compounds and compositions as protease inhibitors
02/25/2003US6524813 Novel polynucleotides and polypeptides of the spo0J family derived from Staphylococcus
02/25/2003US6524623 Therapeutic compositions and methods of use thereof
02/25/2003US6524576 Probiotic composition; veterinary feed additive; food additive; microorganisms dispenser; eliminating an oil pollution; restoring organic fumes degrading microorganism population in a biofilter
02/25/2003US6524575 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
02/21/2003WO2002020462A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
02/21/2003CA2419722A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
02/20/2003WO2003014731A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use
02/20/2003WO2003014728A1 Remedies for hepatitis c
02/20/2003WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
02/20/2003WO2003014326A2 Isolation and mobilization of stem cells expressing vegfr-1
02/20/2003WO2003014316A2 Immunomodulatory compositions, formulations, and methods for use thereof
02/20/2003WO2003014309A2 Interleukin-1 receptors in the treatment of diseases
02/20/2003WO2003014296A2 A group of novel anti-cancer compounds with specific structure
02/20/2003WO2003014294A2 Tacis and br3 polypeptides and uses thereof
02/20/2003WO2003014158A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
02/20/2003WO2003014124A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists
02/20/2003WO2003014123A1 Tricyclic imidazopyridines
02/20/2003WO2003014120A1 Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
02/20/2003WO2003014114A2 Substituted amine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
02/20/2003WO2003014101A1 Hydroxamic acid derivatives
02/20/2003WO2003014098A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
02/20/2003WO2003014097A1 Arylsulfonyl derivatives with 5-ht6 receptor affinity
02/20/2003WO2003014092A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
02/20/2003WO2003014086A1 Process for the preparation of amorphous form of torsemide
02/20/2003WO2003014083A1 Spiro compounds
02/20/2003WO2003014082A1 Cyclopenta ` b ! indole derivatives as spla2 inhibitors
02/20/2003WO2003013614A1 Collagen-containing oral preparations, drugs and quasi drugs
02/20/2003WO2003013600A1 Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other
02/20/2003WO2003013562A1 Artichoke leaf extracts
02/20/2003WO2003013558A1 Treatment of radiation-induced diarrhea with probiotics
02/20/2003WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits
02/20/2003WO2003013537A2 Irinotecan for treatment of cancer
02/20/2003WO2003013536A2 Methods for treatment of cancer using irinotecan based on ugt1a1
02/20/2003WO2003013535A2 Use of irinotecan for improved treatment of cancer based on mdr1
02/20/2003WO2003013534A2 Methods for the treatment of cancer with irinotecan based on cyp3a5
02/20/2003WO2003013533A2 Methods for improved treatment of cancer with irinotecan based on mrp1
02/20/2003WO2003013530A2 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists
02/20/2003WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists.
02/20/2003WO2003013513A1 Stable emulsion composition
02/20/2003WO2003013510A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
02/20/2003WO2003013509A1 N-phenylpyrrole guanidine derivatives as melanocortin reception ligands
02/20/2003WO2003013493A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
02/20/2003WO2003013475A1 Injectable foam and novel pharmaceutical applications thereof
02/20/2003WO2003013440A2 Treatment and prevention of heat shock protein-associated diseases and conditions
02/20/2003WO2003013434A2 Methods and compositions for treating diseases associated with excesses in ace
02/20/2003WO2003013432A2 Methods of use for novel sulfur containing organic nitrate compounds
02/20/2003WO2003013428A2 Nutritional supplements and methods of using same
02/20/2003WO2003013424A2 Use of r-nsaid compounds for anti-hiv treatment
02/20/2003WO2002102794A3 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
02/20/2003WO2002092758A8 Gastrokines and derived peptides including inhibitors
02/20/2003WO2002086085A3 Human timp-1 antibodies
02/20/2003WO2002085368A3 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
02/20/2003WO2002072003A3 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour
02/20/2003WO2002070525A3 Nitrogen-based camptothecin derivatives
1 ... 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 ... 1258